Can we crowdfund clinical research?

Kickstarter for drug trials.

Kickstarter's high-profile launch in the UK last month marks yet another step towards ubiquity for a thoroughly 21st century funding model. Driven by the simplicity of making online payments, crowdfunding sidesteps the limitations of traditional investment channels, instead harnessing the collective power of thousands of small-scale donations from the general public.

Kickstarter might have played host to more than $400 million in crowdfunded pledges since its launch in 2009, but one glance at the site's top ten funded projects – video games, fancy consumer tech, more video games – gives an indication of the relatively narrow scope of the crowdfunding model. Crowdfunding's main niche remains funding creative projects like albums, films and games, where the passion of fans can prompt huge surges in mass donation to bankroll new projects. But as this grass-roots funding method gains traction, new possibilities are beginning to open up.

Take drug development funding. In an era of shrinking government budgets and major funding cuts, could crowdfunding unlock a new source of financial support for the next generation of treatments and cures? Kickstarter excludes health and medical technologies from its fundable projects, but other companies are starting to catch on. MedStartr, a new crowdfunding platform launched this summer, got the ball rolling with a site dedicated to crowdfunding healthcare-related projects like physician videoconferencing, cancer support programmes and therapeutic exercise equipment. But another start-up has taken the concept a step further.

CureLauncher is a recently-launched website dedicated to crowdfunding early-stage clinical development as well as connecting patients and their families to the cutting edge of medical research. The site aims to provide alternative funding for important research projects and clinical trials in the US through large numbers of small contributions, which could be used as primary funding or as bridge funding so projects can continue to develop their science while they wait for federal grants. Like Kickstarter, CureLauncher takes a small percentage of each pledge to make its profit.

The website only launched in October, so doesn't yet have any major success stories to pin on its wall. Nevertheless, if the idea takes off, the potential advantages for US researchers are startling. With the US National Institutes of Health (NIH) facing $2.5 billion in budgets cuts for 2013, CureLauncher offers a platform to galvanise the people affected by chronic diseases and help make up this massive shortfall. 91 per cent of donations go directly to the research projects, and scientists only have to wait 30-45 days for their funds, as opposed to the two years it often takes for NIH funding to materialise. The site only works with heavily scrutinised NIH-level research, which might allay some fears about democratising a traditionally cautious and bureaucratic funding process.

But for CureLauncher's crowdfunding model to thrive in the long-term, it needs to create mass awareness of its sponsored projects, and connect to a large community of funders. That's why its creators, pharma lawyer Steve Goldner and product development expert Dave Fuehrer, have also placed a heavy emphasis on fostering a two-way relationship between researchers and the public. Donors can correspond with the researchers they are donating to, and the site also lists hundreds of enrolling clinical trials – their treatments explained without pharmajargon – so that patients can access early treatment.

It's still early days for CureLauncher, but its founders see the site as a global solution to a global problem, with ambitions to bring struggling research projects outside the US into the fold. It might be too early to tell if the crowdfunding model will work for drug research, but Kickstarter's track record proves that with enough public demand, huge sums of cash can be raised. And if the American public can shell out more than $3 m for a new range of fantasy gaming miniatures, one would hope it can scrape together a few dollars for potentially life-saving medical research.

More can be read here: http://www.pharmaceutical-technology.com/features/featurepeople-power-crowdfunding-clinical-research-funding/

CureLauncher seeks small scale donations. Photograph: Getty Images

 

Chris Lo is a senior technology writer for the NRI Digital network.

Jeremy Corbyn, Labour leader. Getty
Show Hide image

Can Jeremy Corbyn win the 2017 general election?

Does the Labour leader have a chance of becoming prime minister?

 

After less than two years as Labour leader, Jeremy Corbyn is leading the party into a snap general election. This isn’t the first vote of national significance since his election, however, since he was in office during the 2016 EU referendum.

It’s also not his first serious challenge: after the Brexit vote, his MPs voted “no confidence” in him and Owen Smith challenged him for the leadership. Corbyn saw off that threat to his position convincingly, so can he pull out another electoral triumph and become prime minister?

Can Jeremy Corbyn become prime minister? The polls

Since May 2015, the Conservative Party has consistently led in the polls. The latest polls gives Labour ratings in the mid-20s, while the Conservatives are on the mid-40s – numbers which, if borne out at the polls, would give Labour its worst result since 1935.

But should we believe the general election polls? Glen O’Hara, professor of modern and contemporary history at Oxford Brookes University, points out that the polls have been wrong before, and could be overstating Labour’s collapse. However, a 20-point gap is far outside the margin of error. A Corbyn win would be an unprecedented upset.

Can Jeremy Corbyn become prime minister? Electoral record

At the 2016 local elections, Labour did not gain any councils and lost 18 seats and 4% of the vote. James Schneider, the co-founder of Momentum who is now Corbyn’s head of strategic communications, said this showed Labour was on the right trajectory, but it’s a disappointment for an opposition to make no gains. And at the Copeland by-election this February, Labour lost the seat to the Tories – the first government gain in a by-election since 1982.

Can  Jeremy Corbyn become prime minister? The verdict

Jeremy Corbyn’s path to power would be one of the greatest surprises in British politics. But unlikely doesn’t mean impossible. It would take some extraordinary events, but it could happen. Check out the latest odds to see how the markets rate his chances.

0800 7318496